Device type · POE
Extended Depth Of Focus Intraocular Lens
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
POE
Ophthalmic
Device class
Class III
FDA decisions since 2015
3
510(k), De Novo and PMA
Adverse event reports
501
Received Nov 1, 2025 to Nov 19, 2026
How FDA classifies it
- Device type
- Extended Depth Of Focus Intraocular Lens
- Product code
- POE
- Device class
- Class III
- Review panel
- Ophthalmic
- Regulation
- 21 CFR 886.3600
- Specialty
- Ophthalmology
- FDA record
- Classification database entry for POE
Latest FDA decisions
P210005 · Decided Jul 22, 2022 · 513 days after receipt
Device type: Extended depth of focus intraocular lens (POE) · Ophthalmology
- AcrySof IQ Vivity Extended Vision, Toric Extended Vision, Extended Vision UV Absorbing, and Toric Extended Vision UV APMA supplement
P930014-S126 · Decided Feb 26, 2020 · 201 days after receipt · Panel Track
Device type: Extended depth of focus intraocular lens (POE) · Ophthalmology
- TECNIS SYMFONY EXTENDED RANGE OF VISION INTRAOCULAR LENSPMA supplement
Johnson & Johnson Surgical Vision, Inc.
P980040-S065 · Decided Jul 15, 2016 · 178 days after receipt · Panel Track
Device type: Extended depth of focus intraocular lens (POE) · Ophthalmology
Reports received
501
Received Nov 1, 2025 to Nov 19, 2026
Malfunction reports
240
48% of reports
Injury reports
261
52% of reports
Death reports
0
0.0% of reports
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 11 | 29 | 0 | 0 |
| Jan 24 | 11 | 21 | 0 | 0 |
| Feb 24 | 12 | 38 | 0 | 0 |
| Mar 24 | 17 | 49 | 0 | 0 |
| Apr 24 | 21 | 26 | 0 | 0 |
| May 24 | 12 | 52 | 0 | 0 |
| Jun 24 | 8 | 33 | 0 | 0 |
| Jul 24 | 19 | 44 | 0 | 0 |
| Aug 24 | 11 | 22 | 0 | 0 |
| Sep 24 | 12 | 27 | 0 | 0 |
| Oct 24 | 17 | 30 | 0 | 0 |
| Nov 24 | 13 | 29 | 0 | 0 |
| Dec 24 | 25 | 29 | 0 | 0 |
| Jan 25 | 18 | 17 | 0 | 0 |
| Feb 25 | 15 | 21 | 0 | 0 |
| Mar 25 | 24 | 27 | 0 | 0 |
| Apr 25 | 45 | 34 | 0 | 0 |
| May 25 | 20 | 28 | 0 | 0 |
| Jun 25 | 21 | 16 | 0 | 0 |
| Jul 25 | 19 | 23 | 0 | 0 |
| Aug 25 | 18 | 22 | 0 | 0 |
| Sep 25 | 12 | 30 | 0 | 0 |
| Oct 25 | 11 | 24 | 0 | 0 |
| Nov 25 | 12 | 14 | 0 | 0 |
| Dec 25 | 13 | 17 | 0 | 0 |
| Jan 26 | 10 | 16 | 0 | 0 |
| Feb 26 | 10 | 14 | 0 | 0 |
| Mar 26 | 17 | 22 | 0 | 0 |
| Apr 26 | 29 | 22 | 0 | 0 |
| May 26 | 19 | 25 | 0 | 0 |
| Jun 26 | 35 | 24 | 0 | 0 |
| Jul 26 | 32 | 24 | 0 | 0 |
| Aug 26 | 24 | 20 | 0 | 0 |
| Sep 26 | 18 | 38 | 0 | 0 |
| Oct 26 | 21 | 25 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Adverse Event Without Identified Device or Use Problem230
- Break73
- Scratched Material47
- Device Difficult to Setup or Prepare26
- Failure to Deliver22
- Material Twisted/Bent20
- Product Quality Problem17
- Device Dislodged or Dislocated12
- Material Deformation11
- Material Split, Cut or Torn11
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
- No Clinical Signs, Symptoms or Conditions145
- Blurred Vision140
- Insufficient Information101
- Visual Impairment93
- Visual Disturbances87
- Halo18
- Posterior Capsule Opacification14
- Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available9
- Dry Eye(s)8
- Capsular Bag Tear7
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Johnson & Johnson Surgical Vision, Inc.
Z-2288-2023 · Started Jul 6, 2023 · Posted by FDA Aug 3, 2023
Reason given: Their is a potential that intraocular lenses (IOLs) were manufactured with unintended toric fiducial marks.
Cause as FDA categorized it: Under Investigation by firm
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.